EMA reveals date it will begin Amsterdam operations

By Ben Hargreaves contact

- Last updated on GMT

(Image: Getty/Choreograph)
(Image: Getty/Choreograph)

Related tags: Ema, Uk, Netherlands, Brexit

The EMA announces further details on its move from current London headquarters to Amsterdam, which will begin on March 1 and see staff working in its new offices on March 11.

Announcing the initiation of ‘phase 4’ of its business continuity plan, the European Medicines Agency (EMA) provided more details on its relocation from London to Amsterdam​.

Officially, the physical relocation will occur on the week of beginning 4 March, when the agency will “operate on the basis of extended teleworking”​ and a limited number of staff ready to perform ‘emergency’ activities in the Spark building in Amsterdam.

The following week (March 11-15) will see the rest of the EMA staff move into the building.

The agency had previously announced that staff numbers would be reduced during this fourth phase of operations, concluding that 25% of its workforce will not make the move to Amsterdam.

This reduction in workforce will mean that operations at the agency will be reduced, with ‘category 1’ activities (core scientific activities, corporate activities and legal obligations) prioritised. The number of staff choosing not to move with the agency is fewer than had been initially expected​.

Once the move is completed, projected to happen on April 1, 2019, the EMA will review which activities it is able to resume in the second half of the year.

Related topics: Markets & Regulations, Regulations

Related news

Show more

Related products

Transforming Clinical Development

Transforming Clinical Development

PerkinElmer | 01-Jun-2021 | Technical / White Paper

The estimated cost of bringing a drug to market in the U.S. according to JAMA is $1 billion.1 The extreme cost of clinical trials urge biopharmaceutical,...

Vaccine Innovation in the Era of COVID19

Vaccine Innovation in the Era of COVID19

Covance Patient Safety | 01-Oct-2020 | Sponsored Link

During this time of worldwide crisis, there is an increasing demand for the acceleration of a vaccination for COVID19. Regardless of the great recent advancements...

Follow us


View more